Two full days of #EUMDR in Brussels. Thank you Bioevents - Sharing Biomed Knowledge for hosting this event to help professionals with basic MDR knowledge going back to the foundation of the regulation. It was a real workshop which was shaped with my help…https://t.co/WCS1HZAm2P
#Software#validation is key, not just medical devices but all kind of software must be validated to avoid such 🙈 messaging. Check my personal experience with boarding passes the last weeks. Compare boarding time with gate closure time. No comments 😅🤪? https://t.co/Ry4qjhj7VJ
A big thank you for all our customers who value and trust our services. The Team at #AKRATEAM and I will continue do all possible to support devices getting timely to the market ensuring that the healthcare system in the #EU is receiving safe and well-per…https://t.co/LNEIp9yaC5
I missed it this time Oliver Bisazza, but I will be there next time. I just received positive feedback about it 👏 Good job as usual 😉 https://t.co/z51yLsJVEm
Paul Piscoi shared updates from the CI Group during the MedTech Summit 2023
Key ongoing activities:
MEDDEV on clinical evaluation is under update
Device specific guidances are under preparation
SSCP Guidance is under update. Manufacturers will upload…https://t.co/iz6j87T666
Medical background and Statistical Competence are essential in planning, conducting and reporting of successful #Clinical investigation. Very helpful presentation by Shelley Jambresic at #MedTechSummit2023 https://t.co/fusrSTrW1t
Shaloo Sood Kuthiala, PhD from Straumann Group presenting in a simple manner the difference between Hazard, Hazardous Situation and Harm. Check this out!
#RiskManagement#FMEA#MDR https://t.co/JCaVRKTBDq
Good real world experience summary by Wojciech Bobela on Post-Market clinical investigation.
Full Annex XV Requirements Submission is required in #Poland - This is applicable for PMCFs which are in other member states exempted from NCA Approval. Also, F…https://t.co/2IPYfaaxBc
Bianca Lutters presenting on Clinical Investigation Planing to meet EU #MDR
Are sites interested in participation?
Are patient interested to participate?
Is it ethical?
Various questions that must be asked before deciding on the best method to achie…https://t.co/f5RyFy9vl4
Very good recommendations from Shweta Agarwal, PhD and Nataliya Deych at the MedTech Summit 2023
Plan systematically
Request a voluntary scientific opinion if your device is falling under the scope of the expert panel
Ask for a structured conversation w…https://t.co/aIkuBSQJyk
Esther Valk from #Medtronic and Klaus Schichl from #Biotronik presenting on the Q&A from the #MDCG 2021-6
Key message: be careful, the Union Market is still not harmonized. Therefore, it is good to make use of presubmission meetings with the responsible…https://t.co/FGFjTZi6QS
Nebojsa Serafimovic is sharing the regulator’s perspective during the #MedTech Summit in Brussels.
Key information:
1. A new #MEDDEV on clinical evaluation (2.7/1 Rev. 5 or MDCG) is under preparation 🥳
2. In Q4/2024 Switch of national systems to a mand…https://t.co/mYAqgQBsiu
#OMTEC 2023
Looking forward to seeing you all in Chicago. Join us and learn more about the regulatory implications on orthopedic industry.
Gregory Jacobson, @LeanRAQASystems, Matthias Fink, Balazs Bozsik and Dan Goldstein https://t.co/oyqZDYBJVl
Don´t miss this event, join us and learn more about the current interpretation in the EU!
https://t.co/blbDzarnec
#Heartvalve#CEMark#Notifiedbody#ISO https://t.co/3CfkpJs2qC
It is nice being in #Tokyo again, meeting previous TÜV SÜD - Healthcare & Medical Devices Colleagues and enjoying the good food which is typically presented by my good friend Dr. Andreas Stange (The Food Tester 😉). This post is extra for you my friend 😅 https://t.co/A4EaL2AXHF